Dinaqor Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 43

Employees

  • Latest Deal Type
  • Corporate

  • Financing Rounds
  • 1

  • Investments
  • 1

Dinaqor General Information

Description

Developer of gene therapies focused on advancing novel solutions for heart diseases. The company offers genetic medicines and capsids for cardiomyopathies and heart failures, thereby addressing the medical needs of patients with inherited forms of cardiac diseases.

Contact Information

Website
www.dinaqor.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Wagistrasse 25
  • 8952 Schlieren
  • Switzerland
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Drug Delivery
Corporate Office
  • Wagistrasse 25
  • 8952 Schlieren
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dinaqor Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Dinaqor‘s full profile, request access.

Request a free trial

Dinaqor Patents

Dinaqor Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026033115-A2 Lmna gene therapy constructs Pending 09-Aug-2024
WO-2026033115-A3 Lmna gene therapy constructs Pending 09-Aug-2024
EP-4774400-A2 Methods of treatment of hypertrophic cardiomyopathy with aav gene therapy vectors and therapeutic formulations Pending 06-Sep-2023
WO-2025051970-A2 Methods of treatment of hypertrophic cardiomyopathy with aav gene therapy vectors and therapeutic formulations Inactive 06-Sep-2023
WO-2025051970-A3 Methods of treatment of hypertrophic cardiomyopathy with aav gene therapy vectors and therapeutic formulations Inactive 06-Sep-2023 C12N15/86
To view Dinaqor’s complete patent history, request access »

Dinaqor Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dinaqor Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Dinaqor‘s full profile, request access.

Request a free trial

Dinaqor Acquisitions (1)

Dinaqor’s most recent deal was a Merger/Acquisition with DiNABIOS. The deal was made on 19-Jan-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
DiNABIOS 19-Jan-2021 Merger/Acquisition Other Pharmaceuticals and Biotechnology
To view Dinaqor’s complete acquisitions history, request access »

Dinaqor Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
DiNABIOS Zurich, Switzerland 2015

Dinaqor FAQs

  • When was Dinaqor founded?

    Dinaqor was founded in 2019.

  • Where is Dinaqor headquartered?

    Dinaqor is headquartered in Schlieren, Switzerland.

  • What is the size of Dinaqor?

    Dinaqor has 43 total employees.

  • What industry is Dinaqor in?

    Dinaqor’s primary industry is Discovery Tools (Healthcare).

  • Is Dinaqor a private or public company?

    Dinaqor is a Private company.

  • What is Dinaqor’s current revenue?

    The current revenue for Dinaqor is .

  • Who are Dinaqor’s investors?

    BioMarin Pharmaceutical has invested in Dinaqor.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process